| 23/02 | ADAGIO THERAPEUTICS : Announces David Hering Appointed Interim Chief Executive Officer - F.. |  |
| 23/02 | ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Events, Finan.. | |
| 23/02 | Adagio Therapeutics Announces David Hering Appointed Interim Chief Executive Officer | |
| 23/02 | Adagio Therapeutics Announces David Hering Appointed Interim Chief Executive Officer | |
| 22/02 | ADAGIO THERAPEUTICS : Announces CEO Succession Plan - Form 8-K | |
| 22/02 | ADAGIO THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K) | |
| 22/02 | Adagio Therapeutics Announces ADG20 Development Plans and Pipeline Updates | |
| 22/02 | Adagio Therapeutics Announces ADG20 Development Plans and Pipeline Updates | |
| 22/02 | Adagio Therapeutics Announces ADG20 Development Plans and Pipeline Updates | |
| 19/02 | Adagio Therapeutics Announces CEO Succession Plan | |
| 19/02 | Adagio Therapeutics, Inc. Announces Executive Changes | |
| 18/02 | ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K) | |
| 10/02 | Adagio Therapeutics Shares Plummet Amid Lower-Than-Average Volumes | |
| 07/02 | Adagio Therapeutics Shares Rise in Monday Afternoon Trading; Volume Down | |
| 02/02 | Certain Common Stock of Adagio Therapeutics, Inc. are subject to a Lock-Up Agreement En.. | |
| 02/02 | Certain Options of Adagio Therapeutics, Inc. are subject to a Lock-Up Agreement Ending .. | |
| 14/01 | Adagio Therapeutics resume actividad neutralizante de ADG20 contra variantes de SARS-Co.. |  |
| 14/01 | Adagio Therapeutics legt zusammenfassende Ergebnisse zur neutralisierenden Wirkung von .. |  |
| 14/01 | Adagio Therapeutics résume l'activité neutralisante de l'ADG20 contre les variants du S.. |  |
| 13/01 | Wall Street Set for Narrow Gains; US Wholesale Prices Rise Less Than Expected in Decemb.. | |
| 13/01 | Health Care Stocks Mixed Pre-Bell Thursday | |
| 13/01 | SECTOR UPDATE : Health Care | |
| 13/01 | ADAGIO THERAPEUTICS : Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants a.. | |
| 13/01 | ADAGIO THERAPEUTICS, INC. : Regulation FD Disclosure, Other Events, Financial Statements a.. | |
| 13/01 | Top Premarket Gainers | |
| 13/01 | Adagio Therapeutics Reports Neutralization Activity Against Omicron in Phase 2/3 Clinic.. | |
| 12/01 | Adagio Therapeutics Details Omicron-Related Efforts | |
| 12/01 | Adagio Therapeutics Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants .. | |
| 12/01 | Adagio Therapeutics Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants .. | |
| 12/01 | Adagio Therapeutics, Inc. Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Var.. | |
| 07/01 | NORTH AMERICAN MORNING BRIEFING : Stock Futures -2- | |
| 06/01 | Adagio Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference | |
| 2021 | NORTH AMERICAN MORNING BRIEFING : Stocks to Rise -2- | |
| 2021 | Adagio Therapeutics Shares Fall After Jefferies Downgrade | |
| 2021 | ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) added to S&P Biotechnology Select Industry Inde.. | |
| 2021 | ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) added to S&P Global BMI Index | |
| 2021 | Adagio Therapeutics Shares Soar in Midday Trading | |
| 2021 | NORTH AMERICAN MORNING BRIEFING : Stock Futures -3- | |
| 2021 | MÄRKTE USA/Fest - Fed-Beschlüsse wie erwartet | |
| 2021 | MÄRKTE USA/Börse mit leichten Abgaben vor Fed-Entscheid | |
| 2021 | MÄRKTE USA/Wall Street mit leichten Abgaben vor Fed | |
| 2021 | MÄRKTE USA/Wall Street vor Wartemodus auf Fed | |
| 2021 | Health Care Trim Tuesday Retreat, Helped by Late Biotechs Recovery | |
| 2021 | Top Midday Decliners | |
| 2021 | Health Care Stocks Drifting Lower This Afternoon | |
| 2021 | SECTOR UPDATE : Health Care | |
| 2021 | Adagio Therapeutics annonce une réduction de l'activité neutralisante in vitro de l'ADG.. | |
| 2021 | Adagio Therapeutics informa reducción en la actividad neutralizante in vitro de ADG20 c.. | |
| 2021 | Adagio Therapeutics vermeldet eine verminderte neutralisierende Wirkung von ADG20 in vi.. | |
| 2021 | Adagio Therapeutics vermeldet eine verminderte neutralisierende Wirkung von ADG20 in vi.. | |
| 2021 | Health Care Stocks Decline Premarket Tuesday | |
| 2021 | ADAGIO THERAPEUTICS : Reports Reduction in In Vitro Neutralizing Activity of ADG20 Against.. | |
| 2021 | Wall Street Tumbles Pre-Bell, Fed Meeting Eyed | |
| 2021 | ADAGIO THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (f.. | |
| 2021 | Adagio Therapeutics Says Investigational COVID-19 Antibody Treatment Less Effective Aga.. | |
| 2021 | Top Premarket Decliners | |
| 2021 | Adagio Therapeutics Reports Reduction in In Vitro Neutralizing Activity of ADG20 Agains.. | |
| 2021 | Adagio Therapeutics Reports Reduction in Vitro Neutralizing Activity of ADG20 Against O.. | |
| 2021 | Adagio Therapeutics informa de que ninguna de las mutaciones presentes en la variante ó.. | |
| 2021 | Adagio Therapeutics meldet, dass keine der Mutationen der SARS-CoV-2-Variante Omikron i.. | |
| 2021 | ++ Analysen des Tages von Dow Jones Newswires (30.11.2021) +++ | |
| 2021 | NORTH AMERICAN MORNING BRIEFING : -3- | |
| 2021 | HINTERGRUND/Hersteller bereiten Anpassung der Corona-Impfstoffe vor | |
| 2021 | Health Care Stocks Hanging On For Narrow Gains Near Monday Close | |
| 2021 | Health Care Stocks Rising Monday Afternoon | |
| 2021 | SECTOR UPDATE : Health Care | |
| 2021 | Top Midday Gainers | |
| 2021 | ADAGIO THERAPEUTICS : Reports That None of the Mutations Present in SARS-CoV-2 Variant, Om.. | |
| 2021 | ADAGIO THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (f.. | |
| 2021 | Top Premarket Gainers | |
| 2021 | Adagio Therapeutics Stock Surges Pre-Bell on Information Related to ADG20's Effectivene.. | |
| 2021 | Adagio Therapeutics Reports That None of the Mutations Present in SARS-CoV-2 Variant, O.. | |
| 2021 | Adagio Therapeutics Reports That None of the Mutations Present in SARS-CoV-2 Variant, O.. | |
| 2021 | ADAGIO THERAPEUTICS : Announces Expansion of Management Team and Board of Directors to Sup.. | |
| 2021 | ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers, Regulation FD Discl.. | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
Vorig
